Modern psychiatry defines disorders by a checklist of symptoms (e.g., via the DSM), treating the syndrome itself as the disease. This is unlike the rest of medicine, which views symptoms like a cough as signals of various underlying causes. This flawed approach has stalled progress by focusing on labels instead of mechanisms.

The American medical system's emphasis on 15-minute visits and efficiency incentivizes prescribing medication to treat symptoms rather than unraveling root causes. This approach aims to "polish the hood when there's a problem in the engine."

Doctors are often trained to interpret symptoms arising after stopping psychiatric medication as a relapse of the original condition. However, these are frequently withdrawal symptoms. This common misdiagnosis leads to a cycle of re-prescription and prevents proper discontinuation support.

Many people use substances to treat anxiety or depression, not realizing the substance itself causes a dopamine deficit that mimics those conditions. Abstaining for four weeks allows the brain to reset its reward pathways and restore natural dopamine production, often resolving the symptoms entirely.

Research shows that when patients are told they have a chemical imbalance, they feel less in control of their recovery and become more reliant on medication. Framing depression as a manageable response to life stressors fosters a greater sense of agency and optimism.

The widespread belief that depression stems from a chemical imbalance was a successful marketing hypothesis by drug companies, not a scientifically proven fact. After 60 years of research, no consistent evidence supports the theory, yet it drove massive antidepressant adoption.

Contrary to the dominant medical model, mental health issues like depression and anxiety are not illnesses. They are normal, helpful responses that act as messengers, signaling an underlying problem or unresolved trauma that needs to be addressed rather than a chemical imbalance to be suppressed.

Because of receptor saturation, the effect of antidepressants on the brain is not linear. The final few milligrams have a massive impact. Safe tapering requires a hyperbolic curve—making progressively smaller dose reductions to avoid a "cliff-edge" withdrawal effect.

A critical difference between medication and therapy is durability. Studies show when antidepressants are discontinued, depression often returns because the patient hasn't learned new behaviors or coping strategies. Therapy aims to build these skills, making its effects longer-lasting.